Home › Funds › D. E. Shaw & Co., Inc. › NTRA

D. E. Shaw & Co., Inc. position in NTRA

NATERA INC · Health Care

D. E. Shaw & Co., Inc. reported holding 1,279,255 shares of NTRA (NATERA INC) in its Q2 2026 13F filing — a position valued at US$347.3M, representing 0.50% of its reported portfolio and ranking #22 among its reported holdings. D. E. Shaw & Co., Inc. has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.28M sh
Reported value held$347.25M
Portfolio Weight0.50%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How D. E. Shaw & Co., Inc.'s NTRA position evolved

D. E. Shaw & Co., Inc. first disclosed a stake in NTRA in Q3 2023 at 713,979 shares (US$31.6M). The position peaked in Q2 2026 at 1,279,255 shares, worth US$347.3M. Across 12 filings, D. E. Shaw & Co., Inc. increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,279,255 shares valued at US$347.3M — an increase of 787,919 shares quarter over quarter.. Notable position changes include a 533% increase in Q3 2024 (shares rose 24% over the following quarter), a 319% increase in Q4 2025 (shares fell 13% over the following quarter), a 160% increase in Q2 2026 (shares rose 102% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 713.98K $31.59M New
Q4 2023 685.32K $42.93M Reduce
Q1 2024 841.46K $76.96M Add
Q2 2024 1.15M $124.03M Add
Q3 2024 7.25M $24.03M Add
Q4 2024 806.33K $127.64M Reduce
Q1 2025 243.10K $34.38M Reduce
Q2 2025 173.80K $29.36M Reduce
Q3 2025 132.16K $21.27M Reduce
Q4 2025 553.61K $126.83M Add
Q1 2026 491.34K $98.26M Reduce
Q2 2026 1.28M $347.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTRA and 13F data

NTRA (NATERA INC) is a Health Care company. 51 other funds we track also report a position in NTRA — the largest reported positions include JPMorgan Chase & Co (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTRA

All NTRA fund holders →

FAQ

How long has D. E. Shaw & Co., Inc. held NTRA?

D. E. Shaw & Co., Inc. has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is D. E. Shaw & Co., Inc.'s current position in NTRA?

As of Q2 2026, D. E. Shaw & Co., Inc. holds 1.28M shares of NTRA (NATERA INC), valued at $347.25M, representing 0.50% of its reported portfolio and ranking #22.

Has D. E. Shaw & Co., Inc. been buying or selling NTRA?

In the latest 13F filing (Q2 2026), D. E. Shaw & Co., Inc. increased its position in NTRA. The position peaked in Q2 2026 at 1.28M shares.

Which other funds hold NTRA?

Other major institutional holders of NTRA include JPMorgan Chase & Co, Duquesne Family Office LLC, Castle Hook Partners LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.